SCHEMBL472471

SCHEMBL472471

COc1ccc(-c2cnco2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.63
PKM P14618 1/20 0.63
CYP3A4 P08684 1/20 0.63
CYP2D6 P10635 1/20 0.63
LTA4H P09960 1/20 0.62
NOTUM Q6P988 1/20 0.58
GAA P10253 1/20 0.58
PTK2 Q05397 1/20 0.57
KEAP1 Q14145 1/20 0.53
CYP11B1 P15538 1/20 0.51
CYP11B2 P19099 1/20 0.51
IMPDH2 P12268 2/20 0.51
GPR119 Q8TDV5 1/20 0.48
IMPDH1 P20839 2/20 0.48
KCNH2 Q12809 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
EGFR P00533 1/20 0.46
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8005615 0.98 LMNA (0.61) LMNAPKMCYP3A4CYP2D6LTA4H
Oxazole SCHEMBL8006398 0.86 CYP3A4 (0.50) LMNAPKMCYP3A4CYP2D6LTA4H
SCHEMBL10768177 0.83 PKM (0.78) LMNAPKMCYP3A4CYP2D6LTA4H
SCHEMBL31288178 0.80 CYP3A4 (0.77) LMNAPKMCYP3A4CYP2D6LTA4H
SCHEMBL29808022 0.79 KMT2A (0.58) LMNAPKMCYP3A4CYP2D6NOTUM
SCHEMBL83171 0.78 PKM (1.00) LMNAPKMCYP3A4CYP2D6LTA4H
SCHEMBL14129886 0.78 CYP2D6 (1.00) LMNAPKMCYP3A4CYP2D6LTA4H
SCHEMBL31288136 0.77 LMNA (0.53) LMNAPKMCYP3A4CYP2D6LTA4H
SCHEMBL28733682 0.77 LTA4H (0.57) LMNAPKMCYP3A4CYP2D6LTA4H
SCHEMBL12682370 0.77 PDE4A (0.58) LMNAPKMCYP3A4CYP2D6LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024258591-A2 NOVEL INHIBITORS OF HISTONE DEMETHYLASES AND COMPOSITIONS AND METHODS THEREOF XIANG YIBIN (US) 2024-12-19 WO disclosed
CN-115583942-A 2-substituted 5-phenyl-oxazole derivative, preparation method thereof and application thereof as MNK (MNK) inhibitor 中国海洋大学 2023-01-10 CN disclosed
US-20220274968-A1 Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 GBIOTECH S.À.R.L. (CH) 2022-09-01 US disclosed
EP-3212622-B1 BENZYLHYDROXYDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2018-09-26 EP disclosed
US-9878990-B2 Benzylhydroxide derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2018-01-30 US disclosed
US-9878990-B2 Benzylhydroxide derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2018-01-30 US disclosed
US-9878990-B2 Benzylhydroxide derivatives, preparation thereof and therapeutic use thereof SANOFI (FR) 2018-01-30 US disclosed
US-20170313674-A1 BENZYLHYDROXIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2017-11-02 US disclosed
US-20170313674-A1 BENZYLHYDROXIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2017-11-02 US disclosed
US-20170313674-A1 BENZYLHYDROXIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2017-11-02 US disclosed
US-20140275549-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) 2014-09-18 US disclosed
EP-2774923-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE National University Corporation Nagoya University (JP) 2014-09-10 EP disclosed
EP-2774923-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE National University Corporation Nagoya University (JP) 2014-09-10 EP disclosed
EP-2412372-A1 2-Aminooxazole derivatives for use as TRPV1 antagonists for treating i.a. pain, inflammation, neurodegenerative diseases or gastrointestinal diseases Abbott Laboratories (US) 2012-02-01 EP disclosed
US-7998993-B2 TRPV1 antagonists ABBOTT LABORATORIES (US) 2011-08-16 US disclosed
EP-2220059-B1 2-AMINOOXAZOLE DERIVATIVES AS TRPVL ANTAGONISTS USEFUL FOR TREATING PAIN ABBOTT LAB (US) 2011-08-03 EP disclosed
EP-2220059-A1 2-AMINOOXAZOLE DERIVATIVES AS TRPVL ANTAGONISTS USEFUL FOR TREATING PAIN Abbott Laboratories (US) 2010-08-25 EP disclosed
WO-2009075960-A1 CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-18 WO disclosed
US-20090124666-A1 TRPV1 ANTAGONISTS ABBOTT LABORATORIES (US) 2009-05-14 US disclosed
WO-2009055749-A1 2-AMINOOXAZOLE DERIVATIVES AS TRPVL ANTAGONISTS USEFUL FOR TREATING PAIN ABBOTT LABORATORIES (US) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170313674-A1 BENZYLHYDROXIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF CYP11B2, CYP11B1, CYP27A1 LMNA 2114/4885PKM 1149/4885CYP3A4 109/4885
US-20140275549-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE PAH, DDT, NISCH LMNA 4434/4885PKM 1670/4885CYP3A4 75/4885
US-20090124666-A1 TRPV1 ANTAGONISTS TRPV1, TRPV2, TRPV3 LMNA 3611/4885PKM 2086/4885CYP3A4 1644/4885
US-20220274968-A1 Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1 FFAR2, FFAR1, FFAR3 LMNA 4289/4885PKM 2977/4885CYP3A4 1624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.